Association study of polymorphisms in the GluR5 kainate receptor gene (GRIK1) with schizophrenia

The glutamatergic dysfunction hypothesis suggests genes involved in glutamatergic transmission as candidates for schizophrenia susceptibility genes. We screened single nucleotide polymorphisms (SNPs) in the entire coding sequence of the GluR5 kainate receptor gene, GRIK1, by polymerase chain reaction-single strand conformation polymorphism and direct sequencing. We identified six SNPs including three known ones, 522A/C (174T, synonymous), 1173C/T (391D, synonymous), and 2705C/T (902L/S), as well as three novel ones, 995C/T (332A/V), 2400C/T (800L, synonymous), and 2585A/G (862R/Q). We genotyped Japanese samples of schizophrenia (n  = 193–203) and healthy controls (n  = 199–215) for three SNPs those were commonly observed in our samples, 522A/C, 1173C/T, and 2705C/T. We observed no significant associations of the SNPs and their haplotypes with schizophrenia. Therefore, we conclude that GRIK1 does not play a major role in schizophrenia pathogenesis in the Japanese population.

[1]  Y. Fukumaki,et al.  Structure and polymorphisms of the human metabotropic glutamate receptor type 2 gene (GRM2): analysis of association with schizophrenia , 2001, Molecular Psychiatry.

[2]  M. Daly,et al.  A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.

[3]  T. Arinami,et al.  Mutation analysis of the N-methyl-d-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia , 2000, Neuroscience Letters.

[4]  H. Ono,et al.  Novel polymorphism in the gene region encoding the carboxyl-terminal intracellular domain of the NMDA receptor 2B subunit: analysis of association with schizophrenia. , 2000, The American journal of psychiatry.

[5]  N. Risch.  Searching for genetic determinants in the new millennium , 2000, Nature.

[6]  A. Barbon,et al.  Genomic organization, proposed alternative splicing mechanisms, and RNA editing structure of GRIK1 , 2000, Cytogenetic and Genome Research.

[7]  J. Meador-Woodruff,et al.  Glutamate receptor expression in schizophrenic brain , 2000, Brain Research Reviews.

[8]  Marc G Caron,et al.  Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia , 1999, Cell.

[9]  E. Gouaux,et al.  Structure of a glutamate-receptor ligand-binding core in complex with kainate , 1998, Nature.

[10]  B. Moghaddam,et al.  Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. , 1998, Science.

[11]  T. Wienker,et al.  Allelic association of juvenile absence epilepsy with a GluR5 kainate receptor gene (GRIK1) polymorphism. , 1997, American journal of medical genetics.

[12]  Bita Moghaddam,et al.  Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex , 1997, The Journal of Neuroscience.

[13]  T. Sigmundsson,et al.  Exclusion of linkage of schizophrenia of the gene for the glutamate GluR5 receptor , 1997, Biological Psychiatry.

[14]  N Risch,et al.  The Future of Genetic Studies of Complex Human Diseases , 1996, Science.

[15]  B S Weir,et al.  Independence tests for VNTR alleles defined as quantile bins. , 1993, American journal of human genetics.

[16]  J. Nurnberger,et al.  A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. , 1991, Nucleic acids research.

[17]  D. Javitt,et al.  Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.

[18]  G. Rosenbaum,et al.  Study of a new schizophrenomimetic drug; sernyl. , 1959, A.M.A. archives of neurology and psychiatry.

[19]  H. Coon,et al.  Schizophrenia and glutamate receptor genes , 1994, Psychiatric genetics.